Abliva: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
|COST WG4 = WG4}} | |COST WG4 = WG4}} | ||
[[File:NeuroVive.png|right|250px]] | |||
{{Person | {{Person | ||
|lastname=NeuroVive | |lastname=NeuroVive | ||
Line 11: | Line 12: | ||
|country=Sweden | |country=Sweden | ||
|weblink=www.neurovive.com | |weblink=[http://www.neurovive.com www.neurovive.com] | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} |
Revision as of 12:19, 20 January 2017
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Abliva
MitoPedia topics: EAGLE
COST: Member
COST WG4: WG4
Name | NeuroVive , |
---|---|
Institution | NeuroVive Pharmaceutical AB |
Address | Medicon Village, 223 81 |
City | Lund |
State/Province | |
Country | Sweden |
[email protected] | |
Weblink | www.neurovive.com |
O2k-Network Lab | SE Lund Elmer E |
Labels:
Publications
Add references to your publications